XML 54 R45.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CONDENSED INCOME STATEMENT (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues, net $ 22,120,000 $ 15,443,000
Loss from operations 2,101,000 2,917,000
Net loss (2,438,000) 217,000
Melt Pharmaceuticals, Inc. [Member]    
Revenues, net
Loss from operations (3,337,000) (1,099,000)
Net loss $ (3,337,000) $ (1,099,000)